The lower ratio of IGF-1/IGFBP-3 was also observed in patients with NAFLD [77], suggesting that a decrease in circulating free IGF-1 levels may account for exacerbation of insulin resistance and advanced hepatic steatosis. This evidence concerns the gene IGFBP3 and fatty liver disease.